TNF and treatment resistant depression: Available evidence has reported that TNF-α, whose blood concentration has shown a significant improvement after treatments with antidepressants, is the most relevant biomarker to discriminate TRD patients from both to HC and to treatment-responsive MDD patients (55, 74).